Published 6 January 2009, doi:10.1136/bmj.a3188
Cite this as: BMJ 2009;338:a3188

News

US university psychiatrist loses chairmanship over drug company payments

Janice Hopkins Tanne

1 New York

The first 150 words of the full text of this article appear below.

Charles Nemeroff, a psychiatrist and expert in depression and mood and anxiety disorders, has lost his post as chairman of the department of psychiatry and behavioural sciences at Emory University in Atlanta, Georgia, because of payments from drug companies that he had not disclosed.

In October, Dr Nemeroff, who had chaired the department for 17 years, temporarily stepped down after the Senate finance committee found that he had received payments from GlaxoSmithKline and other companies but had not reported them to the university or to the National Institutes of Health as required. Emory then set up a new conflict of interest office (BMJ 2008;337:a2200).

In a statement on 23 December, Emory said that Dr Nemeroff "will remain in the department as a professor and will focus on clinical care, teaching, and other academic pursuits." The university said that it found no evidence that his outside engagements had affected clinical . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

US psychiatrist steps down after questions about drug company payments
Janice Hopkins Tanne
BMJ 2008 337: a2088. [Extract] [Full Text]

Access jobs at BMJ Careers
Whats new online at Student BMJ